Amlodipine Besylate

Amlodipine Besylate is used to treat variant angina pectoris, coronary artery disease and hypertension, per the National Library of Medicine's MED-RT classification. The brand product was first FDA-approved on Jul 31, 1992, and the first generic was approved Oct 3, 2005. FDA's Orange Book lists 60 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $331 million on Amlodipine Besylate across 50.2 million claims for 12.2 million beneficiaries.

Amlodipine Besylate is available as 119 NDCs from 18 manufacturers (109 generic, 10 brand), with NADAC prices from $0.01 to $11.98 per EA — the most expensive product costs about 1,183× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.